Home/ Stocks/ NRSN

NeuroSense Therapeutics Ltd. Ordinary Shares

NRSN XNAS

$0.73 -0.01 (-1.48%) ▼ 15-min delayed

Open

$0.76

High

$0.76

Low

$0.63

Volume

532.6K

Market Cap

$24.75M

About NeuroSense Therapeutics Ltd. Ordinary Shares

NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases. These diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease, and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release or ER, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.

Employees: 15 Website →

Related Market News

No specific coverage for NRSN yet. Check out our latest market news or earnings calendar.

Get NRSN Alerts

Stay ahead with breaking news, price alerts, and expert analysis on NeuroSense Therapeutics Ltd. Ordinary Shares.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.